Guardant Health, Inc. (GH): Total Assets
$2.01B
As of 2025-12-31
$1.91B
As of 2026-06-30
+7.7%
3-year compound annual growth
-2.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.01B | +35.5% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $1.49B | -16.8% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $1.79B | +11.0% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $1.61B | -27.0% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $2.20B | -3.0% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $2.27B | +136.0% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $962.53M | +63.9% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $587.40M | +71.3% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $342.94M | n/a | 2019-03-19, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $3.76B | +14.4% |
| Natera, Inc. (NTRA) | 2025-12-31 | $2.40B | +44.4% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.72B | -24.1% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗